Wenlong Zhai

1.6k total citations · 1 hit paper
59 papers, 1.2k citations indexed

About

Wenlong Zhai is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Wenlong Zhai has authored 59 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 22 papers in Molecular Biology and 17 papers in Cancer Research. Recurrent topics in Wenlong Zhai's work include Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers), Gallbladder and Bile Duct Disorders (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Wenlong Zhai is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers), Gallbladder and Bile Duct Disorders (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Wenlong Zhai collaborates with scholars based in China and United States. Wenlong Zhai's co-authors include Shuijun Zhang, Jie Gao, Qingfang Han, Kaishun Hu, Wenjia Li, Ruo Feng, Chuang Zhou, Renfeng Li, Kunlun Chen and Lei Qi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Wenlong Zhai

56 papers receiving 1.2k citations

Hit Papers

Exosome biogenesis: machinery, regulation, and therapeuti... 2022 2026 2023 2024 2022 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenlong Zhai China 18 765 450 224 216 162 59 1.2k
Junhong Zhao China 19 805 1.1× 469 1.0× 244 1.1× 166 0.8× 120 0.7× 32 1.2k
Xuequan Yao China 20 494 0.6× 305 0.7× 313 1.4× 149 0.7× 172 1.1× 37 921
Weihua Ren China 20 661 0.9× 409 0.9× 258 1.2× 112 0.5× 115 0.7× 43 1.1k
Weiyang He China 18 715 0.9× 343 0.8× 89 0.4× 181 0.8× 154 1.0× 40 1.0k
Christian Mayr Austria 20 632 0.8× 222 0.5× 305 1.4× 204 0.9× 149 0.9× 58 1.1k
Jian Gu China 18 652 0.9× 462 1.0× 128 0.6× 138 0.6× 108 0.7× 46 1.1k
Masayuki Nagahashi Japan 14 503 0.7× 287 0.6× 394 1.8× 134 0.6× 178 1.1× 27 1.0k
Hai Li China 17 532 0.7× 414 0.9× 223 1.0× 126 0.6× 82 0.5× 66 1.2k
Deqiang Wang China 18 506 0.7× 374 0.8× 325 1.5× 116 0.5× 320 2.0× 94 1.1k
Yuanfeng Gong China 18 475 0.6× 321 0.7× 317 1.4× 223 1.0× 129 0.8× 50 1.0k

Countries citing papers authored by Wenlong Zhai

Since Specialization
Citations

This map shows the geographic impact of Wenlong Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenlong Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenlong Zhai more than expected).

Fields of papers citing papers by Wenlong Zhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenlong Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenlong Zhai. The network helps show where Wenlong Zhai may publish in the future.

Co-authorship network of co-authors of Wenlong Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Wenlong Zhai. A scholar is included among the top collaborators of Wenlong Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenlong Zhai. Wenlong Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chong, Jianxiang Shi, Kunlun Chen, et al.. (2025). Single-cell analysis reveals that GFAP+ dedifferentiated Schwann cells promote tumor progress in PNI-positive distal cholangiocarcinoma via lactate/HMGB1 axis. Cell Death and Disease. 16(1). 215–215. 3 indexed citations
5.
Zhang, Jingwei, Zhiqiang Cai, Chen Chen, et al.. (2023). A Bayesian Network Prediction Model for Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma: A Multi‐institutional Study. World Journal of Surgery. 47(3). 773–784. 5 indexed citations
6.
Chen, Chen, Hong Wu, Tianqiang Song, et al.. (2022). Recurrence and prognosis in intrahepatic cholangiocarcinoma patients with different etiology after radical resection: a multi-institutional study. BMC Cancer. 22(1). 329–329. 12 indexed citations
8.
Chen, Chen, Yuhan Wu, Hong Wu, et al.. (2020). [Application value of different lymph node staging system in predicting prognosis of patients with intrahepatic cholangiocarcinoma].. PubMed. 58(4). 295–302. 1 indexed citations
9.
Zhang, Xiaofen, Zijia Zhu, Cai Li, et al.. (2020). Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls. The Journal of Steroid Biochemistry and Molecular Biology. 205. 105775–105775. 25 indexed citations
10.
Chen, Kunlun, Pengfei Zhu, Yuan Liao, et al.. (2019). Oxymatrine inhibits the migration and invasion of hepatocellular carcinoma cells by reducing the activity of MMP-2/-9 via regulating p38 signaling pathway. Journal of Cancer. 10(22). 5397–5403. 19 indexed citations
11.
Zhai, Wenlong, et al.. (2015). Diagnosis and treatment of pancreatic tuberculosis. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 14(5). 429–430.
12.
Zhai, Wenlong, et al.. (2015). Endoplasmic reticulum stress-induced calreticulin translocation to cell surface promotes hepatocellular cancer cells migration and invasion. Zhonghua putong waike zazhi. 30(10). 804–807. 1 indexed citations
13.
Zhai, Wenlong, Ruo Feng, Haiyan Yang, & Yadong Wang. (2015). Note of clarification of data on the association between CYP2E1 RsaI polymorphism and lung cancer risk. European Journal of Cancer. 51(12). 1650–1655. 1 indexed citations
14.
Zhou, Chuang, Yan Zheng, Lin Li, et al.. (2015). Adrenomedullin promotes intrahepatic cholangiocellular carcinoma metastasis and invasion by inducing epithelial-mesenchymal transition. Oncology Reports. 34(2). 610–616. 12 indexed citations
15.
Feng, Ruo, Chuang Zhou, Lei Qi, et al.. (2015). Calreticulin down-regulation inhibits the cell growth, invasion and cell cycle progression of human hepatocellular carcinoma cells. Diagnostic Pathology. 10(1). 149–149. 23 indexed citations
16.
Wang, Yadong, et al.. (2015). Elevated expression of TGIF is involved in lung carcinogenesis. Tumor Biology. 36(12). 9223–9231. 17 indexed citations
17.
Que, Weitao, et al.. (2015). Pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials. The American Journal of Surgery. 209(6). 1074–1082. 41 indexed citations
18.
Gao, Xiangyang, et al.. (2015). Effect of combined treatment with cyclophosphamidum and allicin on neuroblastoma–bearing mice. Asian Pacific Journal of Tropical Medicine. 8(2). 137–141. 21 indexed citations
19.
Wang, Yadong, et al.. (2014). Benzo(a)pyrene promotes A549 cell migration and invasion through up-regulating Twist. Archives of Toxicology. 89(3). 451–458. 48 indexed citations
20.
Zhu, Changlian, Yuchen Wu, Wenlong Zhai, et al.. (2008). Brain Death Affects the Hepatic Immunogenicity of Pigs. Transplantation Proceedings. 40(7). 2159–2162. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026